A community discussion forum with the intent of sharing and developing ways to Think Globally and Act Locally regarding the realization of a Sustainable and Compassionate Revolution for the benefit of all.
Code of Conduct Visibility: open Membership: open Group Email: PCNVRevolutionaries@groups.care2.com
By SHAUN WATERMAN UPI Homeland and National Security Editor
WASHINGTON, Dec. 29, 2006 (UPI) -- The decision by the New York Stock Exchange to list a medical research company targeted by animal rights protestors on a new electronic market where shares can be traded anonymously is being hailed as a victory by animal researchers.
Life Sciences Research, Inc., a Princeton, N.J.-based medical research firm that specializes in animal experiments announced just before Christmas that it had settled a dispute with the NYSE, and would be listed on the exchange's new all-electronic trading platform called Arca.
"We're thrilled," the company's Chief Financial Officer Richard Michaelson told United Press International. "It is a totally anonymous trading environment," he said of the new electronic exchange. "In our situation that is a big advantage."
Life Sciences Research, Inc., is the parent of U.K.-based Huntingdon Life Sciences, and has been targeted on both sides of the Atlantic by animal rights activists organized under the name Stop Huntingdon Animal Cruelty, or SHAC..."
However, 'business' for Life Sciences Research, Inc. could turn very, sour very fast... and millions of frightened, defenseless, innocent animals currently slated for repeated, often excruciatingly painfull procedures, violent treatment, and hopeless lonely deaths could suddenly be free... if The Dr Hadwen Trust for Humane Research, and other animal and consumer protection groups have anything to say about it!!!
AND ALL OF YOU CAN HELP... NO MATTER WHERE YOU LIVE!
"The European legislation governing EU animal experiments (Directive 86/609/EEC), is now some 20 years old, desperately out of date and in urgent need of review. The European Commission has recognised this and a review is now underway. The Commission has also launched an 'Action Plan' that explicitly states "The final aim is to replace animal experiments with methods not entailing the use of an animal."
The revision of Directive 86/609/EEC provides an unprecedented opportunity for the European Union to increase efforts to replace all animal experiments through carefully targeted and co-ordinated research to develop, validate and implement non-animal methods. This could save millions of laboratory animals and improve the quality of research and testing."